Roche to re­file sub­cu­ta­neous Tecen­triq ap­pli­ca­tion with FDA be­fore year’s end on the back of man­u­fac­tur­ing tweaks

Roche plans to file a new ap­pli­ca­tion to the FDA by the end of the year for its sub­cu­ta­neous ver­sion of Tecen­triq, a spokesper­son told …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.